share_log

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Cloonan Michael

SEC announcement ·  Jun 25 05:21
Summary by Futu AI
Michael Cloonan, associated with bluebird bio, Inc. [BLUE], was involved in a transaction on June 20, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. Investors are advised to await further information to fully understand the impact of this event on their investment decisions regarding bluebird bio stock.
Michael Cloonan, associated with bluebird bio, Inc. [BLUE], was involved in a transaction on June 20, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. Investors are advised to await further information to fully understand the impact of this event on their investment decisions regarding bluebird bio stock.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.